BCO three-lens brief
Evidence-based stock research on BCO. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Outperforming SPY by 16.0pp over 30 days. · Debt-to-equity of 1165% — balance-sheet-heavy.
- Outperforming SPY by 16.0pp over 30 days.
- Analyst mean target $145.33 — 24% above current (3 analysts).
- Debt-to-equity of 1165% — balance-sheet-heavy.
- Reported earnings on 2026-11-04.
BCO closed at $116.80 (+0.17%) as of 2026-11-12. Market cap: $4.81B. P/E (trailing) 30.7. Price is above the 50-day MA and above the 200-day MA. Positives: outperforming SPY by 16.0pp over 30 days.; analyst mean target $145.33 — 24% above current (3 analysts).. Concerns: debt-to-equity of 1165% — balance-sheet-heavy.. Last quarter: Revenue $1.38B, net income $14.60M, free cash flow $373.36M.
Why three lenses on BCO, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BCO across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BCO" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BCO brief"></iframe>